secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001493152-26-018590
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio receives Nasdaq deficiency notices for market value requirements
----------------------------------------------------------------------------

- Nasdaq notified Tevogen on Apr 16, 2026 it fails $50M minimum market value for listed securities (MVLS).
- Second notice on Apr 17, 2026 for failing $15M minimum market value of publicly held shares (MVPHS).
- Company has 180 days to regain compliance: MVLS by Oct 13, 2026; MVPHS by Oct 14, 2026.
- Compliance requires closing at or above threshold for 10 consecutive business days.
- Tevogen may consider transferring to Nasdaq Capital Market but provides no assurance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226018590/0001493152-26-018590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226018590/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-018590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer